BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22003372)

  • 1. De-Risking of Stilbazulenyl Nitrone (STAZN), a Lipophilic Nitrone to Treat Stroke Using a Unique Panel of In Vitro Assays.
    Lapchak PA; Schubert DR; Maher PA
    Transl Stroke Res; 2011 Jun; 2(2):209-17. PubMed ID: 22003372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stilbazulenyl nitrone, a second-generation azulenyl nitrone antioxidant, confers enduring neuroprotection in experimental focal cerebral ischemia in the rat: neurobehavior, histopathology, and pharmacokinetics.
    Ley JJ; Vigdorchik A; Belayev L; Zhao W; Busto R; Khoutorova L; Becker DA; Ginsberg MD
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1090-100. PubMed ID: 15716383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stilbazulenyl nitrone, a novel azulenyl nitrone antioxidant: improved neurological deficit and reduced contusion size after traumatic brain injury in rats.
    Belayev L; Becker DA; Alonso OF; Liu Y; Busto R; Ley JJ; Ginsberg MD
    J Neurosurg; 2002 Jun; 96(6):1077-83. PubMed ID: 12066910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stilbazulenyl nitrone, a novel antioxidant, is highly neuroprotective in focal ischemia.
    Ginsberg MD; Becker DA; Busto R; Belayev A; Zhang Y; Khoutorova L; Ley JJ; Zhao W; Belayev L
    Ann Neurol; 2003 Sep; 54(3):330-42. PubMed ID: 12953265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CeeTox™ Analysis of CNB-001 a Novel Curcumin-Based Neurotrophic/Neuroprotective Lead Compound to Treat Stroke: Comparison with NXY-059 and Radicut.
    Lapchak PA; McKim JM
    Transl Stroke Res; 2011 Mar; 2(1):51-9. PubMed ID: 21494575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effect of STAZN, a novel azulenyl nitrone antioxidant, in focal cerebral ischemia in rats: dose-response and therapeutic window.
    Ley JJ; Belayev L; Saul I; Becker DA; Ginsberg MD
    Brain Res; 2007 Nov; 1180():101-10. PubMed ID: 17945201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stilbazulenyl nitrone (STAZN): a nitronyl-substituted hydrocarbon with the potency of classical phenolic chain-breaking antioxidants.
    Becker DA; Ley JJ; Echegoyen L; Alvarado R
    J Am Chem Soc; 2002 May; 124(17):4678-84. PubMed ID: 11971716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. J-147 a Novel Hydrazide Lead Compound to Treat Neurodegeneration: CeeTox
    Lapchak PA; Bombien R; Rajput PS
    J Neurol Neurophysiol; 2013 Aug; 4(3):. PubMed ID: 25364619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stilbazulenyl nitrone decreases oxidative stress and reduces lung injury after hemorrhagic shock/resuscitation and LPS.
    Tawadros PS; Powers KA; Yang I; Becker DA; Ginsberg MD; Szaszi K; Kapus A; Rotstein OD
    Antioxid Redox Signal; 2007 Nov; 9(11):1971-7. PubMed ID: 17715998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel azulenyl nitrone antioxidant protects against MPTP and 3-nitropropionic acid neurotoxicities.
    Yang L; Calingasan NY; Chen J; Ley JJ; Becker DA; Beal MF
    Exp Neurol; 2005 Jan; 191(1):86-93. PubMed ID: 15589515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective antioxidant STAZN protects against myocardial ischemia/reperfusion injury.
    Ley JJ; Prado R; Wei JQ; Bishopric NH; Becker DA; Ginsberg MD
    Biochem Pharmacol; 2008 Jan; 75(2):448-56. PubMed ID: 17936251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic studies on stilbazulenyl-bis-nitrone (STAZN), a nonphenolic chain-breaking antioxidant in solution, micelles, and lipid membranes.
    Mojumdar SC; Becker DA; DiLabio GA; Ley JJ; Barclay LR; Ingold KU
    J Org Chem; 2004 Apr; 69(9):2929-36. PubMed ID: 15104428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-like property profiling of novel neuroprotective compounds to treat acute ischemic stroke: guidelines to develop pleiotropic molecules.
    Lapchak PA
    Transl Stroke Res; 2013 Jun; 4(3):328-42. PubMed ID: 23687519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
    Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
    Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baicalein, an antioxidant 12/15-lipoxygenase inhibitor improves clinical rating scores following multiple infarct embolic strokes.
    Lapchak PA; Maher P; Schubert D; Zivin JA
    Neuroscience; 2007 Dec; 150(3):585-91. PubMed ID: 17942241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin prevents glutamate-induced oxytosis in the HT22 mouse hippocampal cell line through an antioxidant effect specifically targeting mitochondria.
    Herrera F; Martin V; García-Santos G; Rodriguez-Blanco J; Antolín I; Rodriguez C
    J Neurochem; 2007 Feb; 100(3):736-46. PubMed ID: 17263795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenicity and genotoxicity assessment of a new biopreservative product rich in Enterocin AS-48.
    Cascajosa-Lira A; Ai P; M P; A B; E V; A J; Cameán AM
    Food Chem Toxicol; 2020 Dec; 146():111846. PubMed ID: 33166674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinolinyl Nitrone RP19 Induces Neuroprotection after Transient Brain Ischemia.
    Ayuso MI; Martínez-Alonso E; Chioua M; Escobar-Peso A; Gonzalo-Gobernado R; Montaner J; Marco-Contelles J; Alcázar A
    ACS Chem Neurosci; 2017 Oct; 8(10):2202-2213. PubMed ID: 28731692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety evaluation of styrax liquidus from the viewpoint of genotoxicity and mutagenicity.
    Charehsaz M; Reis R; Helvacioglu S; Sipahi H; Guzelmeric E; Acar ET; Cicek G; Yesilada E; Aydin A
    J Ethnopharmacol; 2016 Dec; 194():506-512. PubMed ID: 27737816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.